Lear Corp: Form 10-Q for the period ended Oct 3, 2020
Filed with the SEC on Oct 30, 2020 and accepted by EDGAR at Oct 30, 2020, 09:07 ET.
Management's discussion and analysis
As filed, 67,138 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
EXECUTIVE OVERVIEW
We are a leading Tier 1 supplier to the global automotive industry. We supply seating, electrical distribution systems and electronic modules, as well as related sub-systems, components and software, to all of the world's major automotive manufacturers.
We use our product, design and technological expertise, global reach and competitive manufacturing footprint to achieve our financial goals and objectives of continuing to deliver profitable growth (balancing risks and returns), maintaining a strong balance sheet with investment grade credit metrics and consistently returning excess cash to our stockholders.
Our Seating business consists of the design, development, engineering, just-in-time assembly and delivery of complete seat systems, as well as the design, development, engineering and manufacture of all major seat components, including seat covers and surface materials such as leather and fabric, seat structures and mechanisms, seat foam and headrests. Further, we have capabilities in active sensing and comfort for seats, utilizing electronically controlled sensor and adjustment systems and internally developed algorithms.
Our E-Systems business consists of the design, development, engineering and manufacture of complete electrical distribution systems, as well as sophisticated electronic control modules, electrification products, connectivity products and software solutions for the cloud, vehicles and mobile devices. Electrical distribution systems route networks and electrical signals and manage electrical power within the vehicle for all types of powertrains - from traditional internal combustion engine ("ICE") architectures to the full range of hybrid, plug-in hybrid and battery electric architectures. Key components in our electrical distribution portfolio include wire harnesses, terminals and connectors and junction boxes for both ICE and electrification architectures that require management of higher voltage and power. Electronic control modules facilitate signal, data and power management within the vehicle and include the associated software required to facilitate these functions. Key components in our electronic control module portfolio include body control modules, wireless receiver and transmitter technology and lighting and audio control modules, as well as products specific to electrification and connectivity trends. Electrification products include charging systems (onboard charging modules and cord set charging equipment), battery electronics (battery disconnect units, cell monitoring supervisory systems and integrated total battery control modules) and other power management modules, including converter and inverter systems which may be integrated into other modules or sold separately. Connectivity products include gateway modules and communication modules to manage both wired and wireless networks and data in vehicles. In addition to fully functional electronic modules, we offer software that includes cybersecurity, advanced vehicle positioning for automated and autonomous driving applications, roadside modules that communicate real-time traffic information and full capabilities in both dedicated short-range communication and cellular protocols for vehicle connectivity. Our software solutions also include Xevo Journeyware, a thin-client platform for the cloud, vehicles and mobile devices that enables consumer e-commerce, multi-media applications and enterprise services to improve performance and safety, deliver an artificial intelligence-enhanced driving experience and provide new monetization opportunities for us and the automotive manufacturers, and Xevo Market, an in-vehicle commerce and service platform that connects customers with their favorite brands and services by delivering highly-contextual sales offers through vehicle touch screens and vehicle-branded mobile applications.
We serve all of the world's major automotive manufacturers across both our Seating and E-Systems businesses, and we have automotive content on more than 400 vehicle nameplates worldwide. It is common to have both seating and electrical content on the same and multiple vehicle platforms with a single customer. Further, the seat is becoming a more dynamic and integrated system requiring increased levels of electrical and electronic integration, which is accelerating the convergence of our Seating and E-Systems businesses. We are the only global automotive supplier with complete capabilities in both of these critical business segments. Our businesses benefit globally from leveraging common operating standards and disciplines, including world-class product development and manufacturing processes, as well as common customer support and regional infrastructures. Our core capabilities are shared across component categories and include high-precision manufacturing and assembly with short lead times, management of complex supply chains, global engineering and program management skills, the agility to establish and/or transfer production between facilities quickly and a unique customer-focused culture. Our businesses utilize proprietary, industry-specific processes and standards, leverage common low-cost engineering centers and share centralized operating support functions, such as logistics, supply chain management, quality and health and safety, as well as all major administrative functions.
For further information related to industry trends and our strategy, see Part 1 — Item 1, "Business — Industry and Strategy," of our Annual Report on Form 10-K for the year ended December 31, 2019.
COVID-19 Pandemic
Industry overview
Unprecedented industry disruptions related to the COVID-19 pandemic impacted operations in every region of the world. Global automotive industry production volumes in the first nine months of 2020, as compared to the first nine months of 2019, are shown below (in millions of units):
| Nine Months Ended October 3, 2020 (1) | September 28, 2019 (1) (2) | % Change | |
|---|---|---|---|
| North America | 9.2 | 12.5 | (26)% |
| Europe and Africa | 11.5 | 16.4 | (30)% |
| Asia | 26.4 | 32.5 | (19)% |
| South America | 1.4 | 2.4 | (41)% |
| Other | 1.0 | 1.1 | (8)% |
| Global light vehicle production | 49.4 | 64.9 | (24)% |
(1) Production data based on IHS Automotive
(2) Production data for 2019 has been updated to reflect actual production levels
Our operations in China were impacted first, with most plants in the country closed for several weeks during the first quarter. At the end of the first quarter, all of our facilities in China were operating and capacity utilization was increasing. Beginning in mid-March, our operations in Europe, North America, South America and Asia (outside of China) were impacted, with virtually all of our plants closed at the end of the first quarter and closures continuing throughout April and, in most cases, a portion of May. Although manufacturing resumed gradually, most of our plants in our major markets were operating at pre-COVID-19 levels at the end of the second quarter and throughout the third quarter. We experienced significant inefficiencies and incremental costs related to the COVID-19 pandemic in the first half of the year, which diminished toward the end of the second quarter. In the third quarter, we experienced less significant but ongoing costs related to personal protective equipment, employee transportation and higher labor costs reflecting an increase in absenteeism.
Although industry production has returned to pre-COVID-19 levels, partially due to our customers' need to replenish inventory levels, it is likely that, for a period of time, the global automotive industry will experience lower demand for new vehicles as a result of the global economic slowdown caused by the COVID-19 pandemic, as new vehicle sales are typically correlated with positive consumer confidence and low unemployment. We are also continuing to monitor our supply base, as well as related production constraints imposed by various governments, to minimize the impact on our manufacturing operations. Further, a resurgence of the virus with corresponding shelter-in-place orders impacting industry production later in 2020 or in 2021 could also impact our financial results.
Our percentage of consolidated net sales by region in the first nine months of 2020 and 2019 is shown below:
| Nine Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|
| North America | 40% | 38% |
| Europe and Africa | 36% | 40% |
| Asia | 21% | 19% |
| South America | 3% | 3% |
| Total | 100% | 100% |
Liquidity actions
In response to the COVID-19 pandemic, we took a number of proactive steps to preserve cash and maximize our financial flexibility, including the reduction of discretionary spending, the implementation of salary reductions and deferrals, the reduction of capital expenditures, the aggressive management of working capital and the suspension of share repurchases and quarterly dividends. We are also continuing to seek opportunities offered under government incentive programs throughout the world. In March 2020, we borrowed $1.0 billion under our revolving credit facility, which was repaid in full in September 2020. With $1.25 billion of cash on hand at the end of the third quarter, $1.75 billion of availability under our revolving credit facility and no near-term debt maturities, we believe that we are well positioned to withstand the continuing effects of the COVID-19 pandemic.
Employee protection
Our top priority is to ensure the health and safety of our employees. We have restricted business travel, established protocols for visitors entering our facilities, enhanced disinfection and cleaning procedures at our facilities and promoted social distancing. We have created a Safe Work Playbook, which provides a standardized approach for each of our facilities to create a consistent and safe work environment and offers insights into navigating operational challenges related to the COVID-19 pandemic. The playbook is publicly available and includes health and safety information related to plant operating protocols; employee education, training and feedback; facility assessments; and phased reopening of engineering and administrative centers. All of our facilities and offices are open, and our employees are efficiently working within the new safety protocols.
For risks related to the COVID-19 pandemic, see Part II — Item 1A, "Risk Factors," included in this Report.
Financing Transactions
Senior Notes
In February 2020, we issued $350 million in aggregate principal amount at maturity of 2030 notes (the "2030 Notes") and an additional $300 million in aggregate principal amount at maturity of 2049 notes (the "2049 Notes"). The 2030 Notes have a stated coupon rate of 3.5% and were issued at 99.774% of par, resulting in a yield to maturity of 3.525%. The 2049 Notes have a stated coupon rate of 5.25% and were issued at 106.626% of par, resulting in a yield to maturity of 4.821%.
The net proceeds from the offering were $669 million after original issue discount. The proceeds were used to redeem the $650 million in aggregate principal amount of 2025 notes (the "2025 Notes") at a redemption price equal to 102.625% of the principal amount of such 2025 Notes, plus accrued interest.
In connection with these transactions, we recognized a loss of $21 million on the extinguishment of debt and paid related issuance costs of $6 million.
For further information, see "— Liquidity and Capital Resources — Capitalization — Senior Notes" below and Note 8 "Debt," to the condensed consolidated financial statements included in this Report.
Credit Agreement
Our unsecured credit agreement (the "Credit Agreement"), dated August 8, 2017, consists of a $1.75 billion revolving credit facility (the "Revolving Credit Facility") and a $250 million term loan facility (the "Term Loan Facility"). In February 2020, we entered into an agreement to extend the maturity date of the Revolving Credit Facility by one year to August 8, 2024, and paid related issuance costs of $1 million. The maturity date of the Term Loan Facility remains August 8, 2022.
In March 2020, as a proactive measure in response to the COVID-19 pandemic, we borrowed $1.0 billion under the Revolving Credit Facility, which was repaid in full in September 2020, resulting in availability of $1.75 billion.
For further information, see "— Liquidity and Capital Resources — Capitalization — Credit Agreement" below and Note 8, "Debt," to the condensed consolidated financial statements included in this Report.
Operational Restructuring
In the first nine months of 2020, we incurred pretax restructuring costs of $119 million and related manufacturing inefficiency charges of approximately $4 million, as compared to pretax restructuring costs of $123 million and related manufacturing inefficiency charges of approximately $5 million in the first nine months of 2019. None of the individual restructuring actions initiated during the first nine months of 2020 were material. Our restructuring actions include plant closures and workforce reductions and are initiated to maintain our competitive footprint or are in response to customer initiatives or changes in global and regional automotive markets. Our restructuring actions are designed to maintain or improve our future operating results and profitability throughout the automotive industry cycles. Restructuring actions are generally funded within twelve months of initiation and are funded by cash flows from operating activities and existing cash balances. There have been no changes in previously initiated restructuring actions that have resulted (or will result) in a material change to our restructuring costs. We expect to incur approximately $30 million of additional restructuring costs related to activities initiated as of October 3, 2020, all of which are expected to be incurred by the end of 2021. We plan to implement additional restructuring actions in response to the COVID-19 pandemic in order to align our manufacturing capacity and other costs with prevailing regional automotive production levels. Such future restructuring actions are dependent on market conditions, customer actions and other factors.
For further information, see Note 3, "Restructuring," and Note 17, "Segment Reporting," to the condensed consolidated financial statements included in this Report.
Share Repurchase Program and Quarterly Cash Dividends
Since the first quarter of 2011, our Board of Directors has authorized $6.1 billion in share repurchases under our common stock share repurchase program. In March 2020, as a proactive measure in response to the COVID-19 pandemic, we suspended share repurchases under our share repurchase program. Prior to the suspension, we repurchased $70 million of shares in the first quarter of 2020 and have a remaining repurchase authorization of $1.4 billion, which will expire on December 31, 2022.
In March 2020, as a proactive measure in response to the COVID-19 pandemic, we suspended our quarterly cash dividend. Prior to the suspension, our Board of Directors declared a cash dividend of $0.77 per share of common stock in the first quarter of 2020.
For further information related to our common stock share repurchase program and our quarterly cash dividends, see "— Liquidity and Capital Resources — Capitalization" below and Note 15, "Comprehensive Income (Loss) and Equity," to the condensed consolidated financial statements included in this Report.
Other Matters
In the three months ended October 3, 2020, we recognized tax benefits of $10 million related to the release of a valuation allowance on deferred tax assets and $5 million related to an increase in our research and development tax credits resulting from the completion of a research and development tax credit study, partially offset by net tax expense of $10 million related to restructuring charges and various other items. In the nine months ended October 3, 2020, we recognized tax benefits of $21 million related to a loss on the extinguishment of debt, restructuring charges and various other items and $5 million related to an increase in our research and development tax credits resulting from the completion of a research and development tax credit study, partially offset by net tax expense of $12 million related to a net increase in valuation allowances on deferred tax assets.
In the three and nine months ended September 28, 2019, we recognized a gain of $4 million related to the deconsolidation of an affiliate.
In the three and nine months ended September 28, 2019, we recognized tax benefits of $29 million related to an increase in our research and development tax credits for the years 2013 through 2018. In the three months ended September 28, 2019 we also recognized net tax benefits of $9 million related to restructuring and various other items. In the nine months ended September 28, 2019, we also recognized tax benefits of $18 million related to changes in the tax status of certain affiliates, $3 million related to share-based compensation and $36 million related to restructuring and various other items, partially offset by tax expense of $10 million related to the establishment of a valuation allowance on deferred tax assets of a foreign subsidiary.
As discussed above, our results for the three and nine months ended October 3, 2020 and September 28, 2019, reflect the following items (in millions):
| Three Months Ended October 3, 2020 | September 28, 2019 | Nine Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|---|---|
| Costs related to restructuring actions, including manufacturing inefficiencies of $1 million and $4 million, respectively, in the three and nine months ended October 3, 2020, and $2 million and $5 million, respectively, in the three and nine months ended September 28, 2019 | $50 | $33 | $123 | $128 |
| Acquisition and other related costs | - | - | - | 2 |
| Litigation | - | - | - | 1 |
| Loss on extinguishment of debt | - | - | 21 | 11 |
| Gain related to affiliate | - | (4) | - | (6) |
| Tax benefit, net | (5) | (38) | (14) | (75) |
For further information regarding these items, see Note 3, "Restructuring," Note 8, "Debt," and Note 13, "Income Taxes," to the condensed consolidated financial statements included in this Report.
This Item 2, "Management’s Discussion and Analysis of Financial Condition and Results of Operations," includes forward-looking statements that are subject to risks and uncertainties. For further information regarding other factors that have had, or may have in the future, a significant impact on our business, financial condition or results of operations, see "— Forward-Looking Statements" below and Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019.
RESULTS OF OPERATIONS
A summary of our operating results in millions of dollars and as a percentage of net sales is shown below:
| Net sales | Three Months Ended October 3, 2020 | September 28, 2019 | Nine Months Ended October 3, 2020 | September 28, 2019 | ||||
|---|---|---|---|---|---|---|---|---|
| Seating | $3,691.6 | 75.3% | $3,715.0 | 77.0% | $8,813.1 | 74.7% | $11,468.1 | 76.5% |
| E-Systems | 1,208.5 | 24.7 | 1,110.0 | 23.0 | 2,989.2 | 25.3 | 3,524.6 | 23.5 |
| Net sales | 4,900.1 | 100.0 | 4,825.0 | 100.0 | 11,802.3 | 100.0 | 14,992.7 | 100.0 |
| Cost of sales | 4,457.3 | 91.0 | 4,365.7 | 90.5 | 11,152.7 | 94.5 | 13,582.0 | 90.6 |
| Gross profit | 442.8 | 9.0 | 459.3 | 9.5 | 649.6 | 5.5 | 1,410.7 | 9.4 |
| Selling, general and administrative expenses | 147.7 | 3.0 | 141.9 | 2.9 | 442.3 | 3.7 | 447.3 | 3.0 |
| Amortization of intangible assets | 16.3 | 0.3 | 16.7 | 0.3 | 49.4 | 0.4 | 45.3 | 0.3 |
| Interest expense | 26.5 | 0.5 | 24.0 | 0.5 | 78.1 | 0.7 | 69.4 | 0.4 |
| Other expense, net | 17.1 | 0.3 | 9.7 | 0.2 | 54.4 | 0.5 | 27.9 | 0.2 |
| Provision for income taxes | 44.6 | 0.9 | 33.5 | 0.7 | 30.1 | 0.2 | 149.9 | 1.0 |
| Equity in net income of affiliates | (6.5) | (0.1) | (5.1) | (0.1) | (15.9) | (0.1) | (15.8) | (0.1) |
| Net income attributable to noncontrolling interests | 22.7 | 0.5 | 22.7 | 0.5 | 54.3 | 0.5 | 59.1 | 0.4 |
| Net income (loss) attributable to Lear | $174.4 | 3.6% | $215.9 | 4.5% | $(43.1) | (0.4)% | $627.6 | 4.2% |
Three Months Ended October 3, 2020 vs. Three Months Ended September 28, 2019
Net sales in the third quarter of 2020 were $4.9 billion, as compared to $4.8 billion in the third quarter of 2019, an increase of $75 million or 2%. The impact of new business globally increased net sales by $293 million. This increase was largely offset by lower production volumes on Lear platforms, primarily in Europe, which reduced net sales by $210 million.
(in millions)
| Cost of Sales | |
|---|---|
| Third quarter 2019 | $4,365.7 |
| Material cost | 18.8 |
| Labor and other | 64.6 |
| Depreciation | 8.2 |
| Third quarter 2020 | $4,457.3 |
Cost of sales in the third quarter of 2020 was $4.5 billion, as compared to $4.4 billion in the third quarter of 2019. The impact of new business globally was offset by lower production volumes on Lear platforms, primarily in Europe.
Gross profit and gross margin were $443 million and 9.0% of net sales, respectively, in the third quarter of 2020, as compared to $459 million and 9.5% of net sales, respectively, in the third quarter of 2019. Lower production volumes on Lear platforms and costs related to the COVID-19 pandemic, offset by the impact of new business, reduced gross profit by $35 million. Favorable operating performance, including the benefit of operational restructuring actions, was partially offset by the impact of selling price reductions. These factors had a corresponding impact on gross margin.
Selling, general and administrative expenses, including engineering and development expenses, were $148 million in the third quarter of 2020, as compared to $142 million in the third quarter of 2019. As a percentage of net sales, selling, general and administrative expenses were 3.0% in the third quarter of 2020, as compared to 2.9% in the third quarter of 2019.
Amortization of intangible assets was $16 million in the third quarter of 2020, as compared to $17 million in the third quarter of 2019.
Interest expense was $27 million in the third quarter of 2020, as compared to $24 million in the third quarter of 2019.
Other expense, net, which includes non-income related taxes, foreign exchange gains and losses, gains and losses related to certain derivative instruments and hedging activities, losses on the extinguishment of debt, gains and losses on the disposal of fixed assets, gains and losses on the consolidation and deconsolidation of affiliates, the non-service cost components of net periodic benefit cost and other miscellaneous income and expense, was $17 million in the third quarter of 2020, as compared to $10 million in the third quarter of 2019. In the third quarter of 2020, we recognized a pension settlement loss of $10 million. In the third quarter of 2019, we recognized a gain of $4 million related to the deconsolidation of an affiliate.
In the third quarter of 2020, the provision for income taxes was $45 million, representing an effective tax rate of 19.0% on pretax income before equity in net income of affiliates of $235 million. In the third quarter of 2019, the provision for income taxes was $34 million, representing an effective tax rate of 12.5% on pretax income before equity in net income of affiliates of $267 million, for the reasons described below.
In the third quarters of 2020 and 2019, the provision for income taxes was primarily impacted by the level and mix of earnings among tax jurisdictions. In the third quarter of 2020, we recognized tax benefits of $10 million related to the release of a valuation allowance on deferred tax assets and $5 million related to an increase in our research and development tax credits resulting from the completion of a research and development tax credit study, partially offset by net tax expense of $10 million related to restructuring charges and various other items. In the third quarter of 2019, we recognized tax benefits of $29 million related to an increase in our research and development tax credits for the years 2013 through 2018 and net tax benefits of $9 million related to restructuring and various other items. In addition, we recognized a gain of $4 million related to the deconsolidation of an affiliate, for which no tax expense was provided. Excluding these items, the effective tax rate for the third quarters of 2020 and 2019 approximated the U.S. federal statutory income tax rate of 21%, adjusted for income taxes on foreign earnings, losses and remittances, valuation allowances, tax credits, income tax incentives and other permanent items.
In the third quarters of 2020 and 2019, we measured our tax expense based on the estimated annual effective rate. For further information, see Note 13, "Income Taxes," to the condensed consolidated financial statements included in this Report.
Equity in net income of affiliates was $7 million in the third quarter of 2020, as compared to $5 million in the third quarter of 2019.
Net income attributable to Lear was $174 million, or $2.89 per diluted share, in the third quarter of 2020, as compared to $216 million, or $3.58 per diluted share, in the third quarter of 2019. Net income and diluted net income per share decreased for the reasons described above. In addition, diluted net income per share was impacted by the decrease in average shares outstanding between periods.
Reportable Operating Segments
We have two reportable operating segments: Seating and E-Systems. For a description of our reportable operating segments, see "Executive Overview" above.
The financial information presented below is for our two reportable operating segments and our other category for the periods presented. The other category includes unallocated costs related to corporate headquarters, regional headquarters and the elimination of intercompany activities, none of which meets the requirements for being classified as an operating segment. Corporate and regional headquarters costs include various support functions, such as information technology, advanced research and development, corporate finance, legal, executive administration and human resources. Financial measures regarding each segment’s pretax income before equity in net income of affiliates, interest expense and other expense, net ("segment earnings") and segment earnings divided by net sales ("margin") are not measures of performance under accounting principles generally accepted in the United States ("GAAP"). Segment earnings and the related margin are used by management to evaluate the performance of our reportable operating segments. Segment earnings should not be considered in isolation or as a substitute for net income attributable to Lear, net cash provided by operating activities or other income statement or cash flow statement data prepared in accordance with GAAP or as measures of profitability or liquidity. In addition, segment earnings, as we determine it, may not be comparable to related or similarly titled measures reported by other companies.
For a reconciliation of consolidated segment earnings to consolidated income before provision for income taxes and equity in net income of affiliates, see Note 17, "Segment Reporting," to the condensed consolidated financial statements included in this Report.
Seating
A summary of the financial measures for our Seating segment is shown below (dollar amounts in millions):
| Three Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|
| Net sales | $3,691.6 | $3,715.0 |
| Segment earnings (1) | 250.7 | 281.5 |
| Margin | 6.8% | 7.6% |
(1) See definition above
Seating net sales were $3.7 billion in the third quarters of 2020 and 2019, reflecting a decrease of $23 million or 1%. Lower production volumes on Lear platforms negatively impacted net sales by $189 million. This decrease was largely offset by the impact of new business, which increased net sales by $180 million.
Segment earnings, including restructuring costs, and the related margin on net sales were $251 million and 6.8% in the third quarter of 2020, as compared to $282 million and 7.6% in the third quarter of 2019. Lower production volumes on Lear platforms and costs related to the COVID-19 pandemic, offset by the impact of new business, reduced segment earnings by $36 million. Favorable operating performance, including the benefit of operational restructuring actions, was partially offset by the impact of selling price reductions. Segment earnings were also negatively impacted by higher restructuring costs.
E-Systems
A summary of financial measures for our E-Systems segment is shown below (dollar amounts in millions):
| Three Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|
| Net sales | $1,208.5 | $1,110.0 |
| Segment earnings(1) | 86.0 | 74.3 |
| Margin | 7.1% | 6.7% |
(1) See definition above
E-Systems net sales were $1.2 billion in the third quarter of 2020, as compared to $1.1 billion in the third quarter of 2019, an increase of $99 million or 9%. The impact of new business increased net sales by $113 million. This increase was partially offset by lower production volumes on Lear platforms, which reduced net sales by $21 million.
Segment earnings, including restructuring costs, and the related margin on net sales were $86 million and 7.1% in the third quarter of 2020, as compared to $74 million and 6.7% in the third quarter of 2019. The impact of new business was offset by lower production volumes on Lear platforms and costs related to the COVID-19 pandemic. Improved operating performance and lower restructuring costs was partially offset by the impact of selling price reductions.
Other
A summary of financial measures for our other category, which is not an operating segment, is shown below (dollar amounts in millions):
| Three Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|
| Net sales | $- | $- |
| Segment earnings (1) | (57.9) | (55.1) |
| Margin | N/A | N/A |
(1) See definition above
Segment earnings related to our other category were ($58) million in the third quarter of 2020, as compared to ($55) million in the third quarter of 2019.
Nine Months Ended October 3, 2020 vs. Nine Months Ended September 28, 2019
Net sales for the nine months ended October 3, 2020 were $11.8 billion, as compared to $15.0 billion for the nine months ended September 28, 2019, a decrease of $3.2 billion or 21%. Lower production volumes on Lear platforms globally, largely due to the COVID-19 pandemic, negatively impacted net sales by more than $3.2 billion.
(in millions)
| Cost of Sales | |
|---|---|
| First nine months of 2019 | $13,582.0 |
| Material cost | (2,151.2) |
| Labor and other | (291.1) |
| Depreciation | 13.0 |
| First nine months of 2020 | $11,152.7 |
Cost of sales in the first nine months of 2020 were $11.2 billion, as compared to $13.6 billion in the first nine months of 2019. Lower production volumes on Lear platforms globally, largely due to the COVID-19 pandemic, reduced cost of sales by more than $2.5 billion.
Gross profit and gross margin were $650 million and 5.5% of net sales, respectively, for the nine months ended October 3, 2020, as compared to $1.4 billion and 9.4% of net sales, respectively, for the nine months ended September 28, 2019. Lower production volumes on Lear platforms globally, largely due to the COVID-19 pandemic, and costs related to the COVID-19 pandemic negatively impacted gross profit by $786 million. Favorable operating performance, including the benefit of operational restructuring actions, and lower restructuring costs was offset by the impact of selling price reductions. These factors had a corresponding impact on gross margin.
Selling, general and administrative expenses, including engineering and development expenses, were $442 million in the first nine months of 2020, as compared to $447 million in the first nine months of 2019. As a percentage of net sales, selling, general and administrative expenses were 3.7% in the first nine months of 2020, as compared to 3.0% in the first nine months of 2019, reflecting the significant decrease in net sales in 2020.
Amortization of intangible assets was $49 million in the first nine months of 2020, as compared to $45 million in the first nine months of 2019.
Interest expense was $78 million in the first nine months of 2020, as compared to $69 million in the first nine months of 2019.
Other expense, net, which includes non-income related taxes, foreign exchange gains and losses, gains and losses related to certain derivative instruments and hedging activities, losses on the extinguishment of debt, gains and losses on the disposal of fixed assets, gains and losses on the consolidation and deconsolidation of affiliates, the non-service cost components of net periodic benefit cost and other miscellaneous income and expense, was $54 million for the nine months ended October 3, 2020, as compared to $28 million for the nine months ended September 28, 2019. In the first nine months of 2020, we recognized a loss of $21 million related to the extinguishment of debt and a pension settlement loss of $10 million. In the first nine months of 2019, we recognized a loss of $11 million related to the extinguishment of debt and a gain of $4 million related to the deconsolidation of an affiliate.
For the nine months ended October 3, 2020, the provision for income taxes was $30 million, representing an effective tax rate of 118.5% on pretax income before equity in net income of affiliates of $25 million. For the nine months ended September 28, 2019, the provision for income taxes was $150 million, representing an effective tax rate of 18.3% on pretax income before equity in net income of affiliates of $821 million. In the first nine months of 2020, pretax income before equity in net income of affiliates was significantly lower than in the first nine months of 2019, primarily due to the COVID-19 pandemic, and as a result, relatively small changes in the provision for income taxes in 2020 can cause disproportionate changes in the effective tax rate as compared to 2019. The higher effective tax rate in the first nine months of 2020, as compared to the first nine months of 2019, was also due to the net discrete tax expense and lower tax benefit on our restructuring charges and various other items in 2020.
In the first nine months of 2020 and 2019, the provision for income taxes was primarily impacted by the level and mix of earnings among tax jurisdictions. In the first nine months of 2020, we recognized tax benefits of $21 million related to a loss on the extinguishment of debt, restructuring charges and various other items and $5 million related to an increase in our research and development tax credits resulting from the completion of a research and development tax credit study, partially offset by net tax expense of $12 million related to a net increase in valuation allowances on deferred tax assets. In the first nine months of 2019, we recognized tax benefits of $29 million related to an increase in our research and development tax credits for the years 2013 through 2018, $18 million related to changes in the tax status of certain affiliates, $3 million related to share-based compensation and $36 million related to restructuring and various other items, partially offset by tax expense of $10 million related to the establishment of a valuation allowance on deferred tax assets of a foreign subsidiary. In addition, we recognized a gain of $4 million related to the deconsolidation of an affiliate, for which no tax expense was provided.
In the first nine months of 2020 and 2019, we measured our tax expense based on the estimated annual effective rate. For further information, see Note 13, "Income Taxes," to the condensed consolidated financial statements included in this Report.
Equity in net income of affiliates was $16 million in the first nine months of 2020 and 2019.
Net income (loss) attributable to Lear was ($43) million, or ($0.72) per diluted share, for the nine months ended October 3, 2020, as compared to $628 million, or $10.23 per diluted share, for the nine months ended September 28, 2019. Net income (loss) and diluted net income (loss) per share decreased for the reasons described above. In addition, diluted net income (loss) per share was impacted by the decrease in average shares outstanding between periods.
Reportable Operating Segments
We have two reportable operating segments: Seating and E-Systems. For a description of our reportable operating segments, see "Executive Overview" and "Three Months Ended October 3, 2020 vs. Three Months Ended September 28, 2019 — Reportable Operating Segments" above.
Seating
A summary of the financial measures for our Seating segment is shown below (dollar amounts in millions):
| Nine Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|
| Net sales | $8,813.1 | $11,468.1 |
| Segment earnings (1) | 320.4 | 817.0 |
| Margin | 3.6% | 7.1% |
(1) See definition above
Seating net sales were $8.8 billion for the nine months ended October 3, 2020, as compared to $11.5 billion for the nine months ended September 28, 2019, a decrease of $2.7 billion or 23%. Lower production volumes on Lear platforms globally, largely due to the COVID-19 pandemic, negatively impacted net sales by nearly $2.7 billion.
Segment earnings, including restructuring costs, and the related margin on net sales were $320 million and 3.6% for the nine months ended October 3, 2020, as compared to $817 million and 7.1% for the nine months ended September 28, 2019. Lower production volumes on Lear platforms globally, largely due to the COVID-19 pandemic, and costs related to the COVID-19 pandemic negatively impacted segment earnings by $587 million. Favorable operating performance, including the benefit of operational restructuring actions, was partially offset by the impact of selling price reductions. Segment earnings were also favorably impacted by lower restructuring costs.
E-Systems
A summary of financial measures for our E-Systems segment is shown below (dollar amounts in millions):
| Nine Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|
| Net sales | $2,989.2 | $3,524.6 |
| Segment earnings (1) | 5.0 | 287.3 |
| Margin | 0.2% | 8.2% |
(1) See definition above
E-Systems net sales were $3.0 billion for the nine months ended October 3, 2020, as compared to $3.5 billion for the nine months ended September 28, 2019, a decrease of $535 million or 15%. Lower production volumes on Lear platforms globally, largely due to the COVID-19 pandemic, negatively impacted net sales by more than $600 million.
Segment earnings, including restructuring costs, and the related margin on net sales were $5 million and 0.2% for the nine months ended October 3, 2020, as compared to $287 million and 8.2% for the nine months ended September 28, 2019. Lower production volumes on Lear platforms globally, largely due to the COVID-19 pandemic, and costs related to the COVID-19 pandemic negatively impacted segment earnings by $224 million. Improved operating performance was more than offset by the impact of selling price reductions and, to a lesser extent, higher restructuring costs.
Other
A summary of financial measures for our other category, which is not an operating segment, is shown below (dollar amounts in millions):
| Nine Months Ended October 3, 2020 | September 28, 2019 | |
|---|---|---|
| Net sales | $- | $- |
| Segment earnings(1) | (167.5) | (186.2) |
| Margin | N/A | N/A |
(1) See definition above
Segment earnings related to our other category were ($168) million in the first nine months of 2020, as compared to ($186) million in the first nine months of 2019, primarily reflecting lower compensation-related costs in 2020.
LIQUIDITY AND CAPITAL RESOURCES
Our primary liquidity needs are to fund general business requirements, including working capital requirements, capital expenditures, operational restructuring actions and debt service requirements. Our principal sources of liquidity are cash flows from operating activities, borrowings under available credit facilities and our existing cash balance.
Adequacy of Liquidity Sources
As of October 3, 2020, we had $1.25 billion of cash and cash equivalents on hand and $1.75 billion in available borrowing capacity under our Revolving Credit Facility. Together with cash provided by operating activities, we believe that this will enable us to meet our liquidity needs for the foreseeable future and to satisfy ordinary course business obligations.
In response to the COVID-19 pandemic, we took a number of proactive steps to preserve cash and maximize our financial flexibility in order to efficiently manage through the COVID-19 pandemic, including:
- Aggressively reducing operating costs, capital expenditures and working capital, including reducing discretionary spending
- Reducing salaried employee costs throughout the organization through salary reductions and deferrals
- Suspending share repurchases and quarterly dividends
- Maximizing opportunities offered under government incentive programs throughout the world
- Reducing the compensation of the Board of Directors
- Reducing hourly factory worker costs through temporary layoffs
- Delaying planned pension funding and deferring other retirement plan contributions
Our future financial results and our ability to continue to meet our liquidity needs are subject to, and will be affected by, cash flows from operations, including the continuing effects of the COVID-19 pandemic, as well as restructuring activities, automotive industry conditions, the financial condition of our customers and suppliers and other related factors.
For further discussion of the risks and uncertainties affecting our cash flows from operations and our overall liquidity, see "— Executive Overview" above, "— Forward-Looking Statements" below, Part II — Item 1A, "Risk Factors," included in this Report and Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019.
Cash Provided by Subsidiaries
A substantial portion of our operating income is generated by our subsidiaries. As a result, we are dependent on the earnings and cash flows of and the combination of dividends, royalties, intercompany loan repayments and other distributions and advances from our subsidiaries to provide the funds necessary to meet our obligations.
As of October 3, 2020 and December 31, 2019, cash and cash equivalents of $788 million and $895 million, respectively, were held in foreign subsidiaries and can be repatriated, primarily through the repayment of intercompany loans and the payment of dividends, without creating additional income tax expense. There are no significant restrictions on the ability of our subsidiaries to pay dividends or make other distributions to Lear.
For further information related to potential dividends from our non-U.S. subsidiaries, see Note 8, "Income Taxes," to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019.
Cash Flows
A summary of net cash provided by operating activities is shown below (in millions):
| Nine Months Ended October 3, 2020 | September 28, 2019 | Increase (Decrease) in Operating Cash Flow | |
|---|---|---|---|
| Consolidated net income and depreciation and amortization | $408 | $1,067 | $(659) |
| Net change in working capital items: | |||
| Accounts receivable | (417) | (513) | 96 |
| Inventory | (14) | (124) | 110 |
| Accounts payable | 124 | 209 | (85) |
| Accrued liabilities and other | 169 | 266 | (97) |
| Net change in working capital items | (138) | (162) | 24 |
| Other | (8) | (106) | 98 |
| Net cash provided by operating activities | $262 | $799 | $(537) |
In the first nine months of 2020 and 2019, net cash provided by operating activities was $262 million and $799 million, respectively. The overall decrease in operating cash flows of $537 million was primarily due to lower earnings in 2020.
Net cash used in investing activities was $297 million in the first nine months of 2020, as compared to $739 million in the first nine months of 2019. In the first nine months of 2019, we paid $322 million for the acquisition of Xevo. Capital spending was $285 million in the first nine months of 2020, as compared to $410 million in the first nine months of 2019. Capital spending is estimated to be approximately $425 million in 2020, which reflects a delay in certain program launches and a reduction in discretionary spending in response to the COVID-19 pandemic.
Net cash used in financing activities was $212 million in the first nine months of 2020, as compared to $237 million in the first nine months of 2019. In the first quarter of 2020, we borrowed $1.0 billion under the Revolving Credit Facility as a proactive measure in response to the COVID-19 pandemic, which was repaid in full in the third quarter of 2020. In 2020, we received net proceeds of $669 million related to the issuance of the 2030 and additional 2049 Notes and paid $6 million of related issuance costs and $667 million related to the redemption of the outstanding 2025 Notes. Also in 2020, we paid $70 million for repurchases of our common stock, $52 million of dividends to Lear stockholders and $46 million of dividends to noncontrolling interest holders. In 2019, we received net proceeds of $693 million related to the issuance of the 2029 and 2049 Notes and paid $6 million of related issuance costs and $334 million related to the redemption of the outstanding 2024 Notes. Also in 2019, we paid $360 million for repurchases of our common stock, $141 million of dividends to Lear stockholders and $34 million of dividends to noncontrolling interest holders.
Capitalization
From time to time, we utilize uncommitted credit facilities to fund our capital expenditures and working capital requirements at certain of our foreign subsidiaries, in addition to cash provided by operating activities. The availability of uncommitted lines of credit may be affected by our financial performance, credit ratings and other factors. As of October 3, 2020 and December 31, 2019, our short-term borrowings outstanding were $4 million and $19 million, respectively.
Senior Notes
As of October 3, 2020, our senior notes (collectively, the "Notes") consisted of the amounts shown below (in millions, except stated coupon rates):
| Note | Aggregate Principal Amount at Maturity | Stated Coupon Rate |
|---|---|---|
| Senior unsecured notes due 2027 (the "2027 Notes") | 750 | 3.80% |
| Senior unsecured notes due 2029 (the "2029 Notes") | 375 | 4.25% |
| 2030 Notes | 350 | 3.50% |
| 2049 Notes | 625 | 5.25% |
| $2,100 |
The issue, maturity and interest payment dates of the Notes are shown below:
| Note | Issuance Date(s) | Maturity Date | Interest Payment Dates |
|---|---|---|---|
| 2027 Notes | August 2017 | September 15, 2027 | March 15 and September 15 |
| 2029 Notes | May 2019 | May 15, 2029 | May 15 and November 15 |
| 2030 Notes | February 2020 | May 30, 2030 | May 30 and November 30 |
| 2049 Notes | May 2019 and February 2020 | May 15, 2049 | May 15 and November 15 |
In February 2020, we issued $350 million in aggregate principal amount at maturity of 2030 Notes and an additional $300 million in aggregate principal amount at maturity of 2049 Notes. The 2030 Notes have a stated coupon rate of 3.5% and were issued at 99.774% of par, resulting in a yield to maturity of 3.525%. The 2049 Notes have a stated coupon rate of 5.25% and were issued at 106.626% of par, resulting in a yield to maturity of 4.821%.
The net proceeds from the offering were $669 million after original issue discount. The proceeds were used to redeem the $650 million in aggregate principal amount of 2025 Notes at a redemption price equal to 102.625% of the principal amount of such 2025 Notes, plus accrued interest.
In connection with these transactions, we recognized a loss of $21 million on the extinguishment of debt and paid related issuance costs of $6 million.
The indentures governing the Notes contain certain investment-grade style restrictive covenants and customary events of default. As of October 3, 2020, we were in compliance with all covenants under the indentures governing the Notes.
For further information related to the Notes, including information on early redemption, covenants and events of default, see Note 8, "Debt," to the condensed consolidated financial statements included in this Report and Note 6, "Debt," to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019.
Credit Agreement
Our Credit Agreement, dated August 8, 2017, consists of a $1.75 billion Revolving Credit Facility and a $250 million Term Loan Facility. In February 2020, we entered into an agreement to extend the maturity date of the Revolving Credit Facility by one year to August 8, 2024, and paid related issuance costs of $1 million. The maturity date of the Term Loan Facility remains August 8, 2022.
In March 2020, as a proactive measure in response to the COVID-19 pandemic, we borrowed $1.0 billion under the Revolving Credit Facility, which was repaid in full in September 2020.
As of October 3, 2020 and December 31, 2019, there were $225 million and $234 million of borrowings outstanding under the Term Loan Facility, respectively. During the first nine months of 2020, we made required principal payments of $9 million under the Term Loan Facility.
The Credit Agreement contains various financial and other covenants that require us to maintain a minimum leverage coverage ratio. As of October 3, 2020, we were in compliance with all covenants under the Credit Agreement. Although we expect to maintain compliance with all covenants, the impact of the COVID-19 pandemic may negatively affect our ability to comply with certain of these covenants. In the event that we are unable to maintain compliance with such covenants, we expect to obtain an amendment or waiver from our lenders, refinance the indebtedness subject to the covenants or take other mitigating actions prior to a potential breach.
For further information related to the Credit Agreement, including information on pricing, covenants and events of default, see Note 8, "Debt," to the condensed consolidated financial statements included in this Report and Note 6, "Debt," to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019.
Accounts Receivable Factoring
During the second quarter of 2020, we entered into an uncommitted factoring arrangement which provides for aggregate purchases of specified customer accounts in North America. The factoring arrangement results in true sales of the factored receivables, which are excluded from amounts reported in the consolidated balance sheets when the receivables are factored in accordance with ASC 860, "Transfers and Servicing." There were no receivables factored during the first nine months of 2020. We cannot provide any assurances that the factoring arrangement will be available or utilized in the future.
Common Stock Share Repurchase Program
In March 2020, as a proactive measure in response to the COVID-19 pandemic, we suspended share repurchases under our share repurchase program. Share repurchases prior to the suspension are shown below (in millions except for shares and per share amounts):
| Nine Months Ended October 3, 2020 Aggregate Repurchases | Cash paid for Repurchases | Number of Shares | Average Price per Share(1) | As of October 3, 2020 Remaining Purchase Authorization |
|---|---|---|---|---|
| $70 | $70 | 641,149 | $109.22 | $1,430 |
(1) Excludes commissions
Since the first quarter of 2011, our Board of Directors has authorized $6.1 billion in share repurchases under our common stock share repurchase program. As of the end of the third quarter of 2020, we have repurchased, in aggregate, $4.7 billion of our outstanding common stock, at an average price of $90.07 per share, excluding commissions and related fees.
We may implement share repurchases through a variety of methods, including, but not limited to, open market purchases, accelerated stock repurchase programs and structured repurchase transactions. The extent to which we will repurchase our outstanding common stock and the timing of such repurchases will depend upon our financial condition, prevailing market conditions, alternative uses of capital and other factors (see "— Forward-Looking Statements").
For further information related to our common stock share repurchase program, see Note 15, "Comprehensive Income (Loss) and Equity," to the condensed consolidated financial statements included in this Report.
Dividends
In March 2020, as a proactive measure in response to the COVID-19 pandemic, we suspended our quarterly cash dividend. A summary of the first quarter 2020 dividend (prior to the suspension) is shown below:
| Payment Date | Dividend Per Share | Declaration Date | Record Date |
|---|---|---|---|
| March 18, 2020 | $0.77 | February 6, 2020 | February 28, 2020 |
Although we do expect to pay quarterly cash dividends at some point in the future, such payments are at the discretion of our Board of Directors and will depend upon our financial condition, results of operations, capital requirements, alternative uses of capital and other factors that our Board of Directors may consider in its discretion.
Market Risk Sensitivity
In the normal course of business, we are exposed to market risks associated with fluctuations in foreign exchange rates, interest rates and commodity prices. We manage a portion of these risks through the use of derivative financial instruments in accordance with our policies. We enter into all hedging transactions for periods consistent with the underlying exposures. We do not enter into derivative instruments for trading purposes.
Foreign Exchange
Operating results may be impacted by our buying, selling and financing in currencies other than the functional currency of our operating companies ("transactional exposure"). We may mitigate a portion of this risk by entering into forward foreign exchange, futures and option contracts. The foreign exchange contracts are executed with banks that we believe are creditworthy. Gains and losses related to foreign exchange contracts are deferred where appropriate and included in the measurement of the foreign currency transaction subject to the hedge. Gains and losses incurred related to foreign exchange contracts are generally offset by the direct effects of currency movements on the underlying transactions.
A summary of the notional amount and estimated aggregate fair value of our outstanding foreign exchange contracts is shown below (in millions):
| October 3, 2020 | December 31, 2019 | |
|---|---|---|
| Notional amount (contract maturities < 24 months) | $2,954 | $2,163 |
| Fair value | (3) | 50 |
Currently, our most significant foreign currency transactional exposures relate to the Mexican peso, various European currencies, the Chinese renminbi, the Thai baht, the Japanese yen, the Honduran lempira and the Brazilian real. A sensitivity analysis of our net transactional exposure is shown below (in millions):
| Hypothetical Strengthening % (1) | Potential Earnings Benefit (Adverse Earnings Impact) October 3, 2020 | December 31, 2019 | |
|---|---|---|---|
| U.S. dollar | 10% | $26 | $(16) |
| Euro | 10% | (4) | 19 |
(1) Relative to all other currencies to which it is exposed for a twelve-month period
A sensitivity analysis related to the aggregate fair value of our outstanding foreign exchange contracts is shown below (in millions):
| Hypothetical Change % (2) | Estimated Change in Fair Value October 3, 2020 | December 31, 2019 | |
|---|---|---|---|
| U.S. dollar | 10% | $63 | $50 |
| Euro | 10% | 62 | 69 |
(2) Relative to all other currencies to which it is exposed for a twelve-month period
There are certain shortcomings inherent in the sensitivity analyses above. The analyses assume that all currencies would uniformly strengthen or weaken relative to the U.S. dollar or Euro. In reality, some currencies may strengthen while others may weaken, causing the earnings impact to increase or decrease depending on the currency and the direction of the rate movement.
In addition to the transactional exposure described above, our operating results are impacted by the translation of our foreign operating income into U.S. dollars ("translational exposure"). In 2019, net sales outside of the United States accounted for 82% of our consolidated net sales, although certain non-U.S. sales are U.S. dollar denominated. We do not enter into foreign exchange contracts to mitigate our translational exposure.
Commodity Prices
Raw material, energy and commodity costs can be volatile, reflecting changes in supply and demand and global trade and tariff policies. We have developed and implemented strategies to mitigate the impact of higher raw material, energy and commodity costs, such as the selective in-sourcing of components, the continued consolidation of our supply base, longer-term purchase commitments and the selective expansion of low-cost country sourcing and engineering, as well as value engineering and product benchmarking. However, these strategies, together with commercial negotiations with our customers and suppliers, typically offset only a portion of the adverse impact. Certain of these strategies also may limit our opportunities in a declining commodity cost environment. If these costs increase, it could have an adverse impact on our operating results in the foreseeable future. See "— Forward-Looking Statements" below and Item 1A, "Risk Factors — Increases in the costs and restrictions on the availability of raw materials, energy, commodities and product components could adversely affect our financial performance," in our Annual Report on Form 10-K for the year ended December 31, 2019.
We have commodity price risk with respect to purchases of certain raw materials, including steel, copper, diesel fuel, chemicals, resins and leather. Our main cost exposures relate to steel, copper and leather. The majority of the steel used in our products is comprised of fabricated components that are integrated into a seat system, such as seat frames, recliner mechanisms, seat tracks and other mechanical components. Therefore, our exposure to changes in steel prices is primarily indirect, through these purchased components. Approximately 91% of our copper purchases and a significant portion of our leather purchases are subject to price index agreements with our customers and suppliers.
For further information related to the financial instruments described above, see Note 18, "Financial Instruments," to the condensed consolidated financial statements included in this Report.
OTHER MATTERS
Legal and Environmental Matters
We are involved from time to time in various legal proceedings and claims, including, without limitation, commercial and contractual disputes, product liability claims and environmental and other matters. As of October 3, 2020, we had recorded reserves for pending legal disputes, including commercial disputes and other matters, of $16 million. In addition, as of October 3, 2020, we had recorded reserves for product liability claims and environmental matters of $45 million and $9 million, respectively. Although these reserves were determined in accordance with GAAP, the ultimate outcomes of these matters are inherently uncertain, and actual results may differ significantly from current estimates. For a description of risks related to various legal proceedings and claims, see Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019. For a more complete description of our outstanding material legal proceedings, see Note 16, "Legal and Other Contingencies," to the condensed consolidated financial statements included in this Report.
Significant Accounting Policies and Critical Accounting Estimates
Certain of our accounting policies require management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. However, these estimates and assumptions are subject to an inherent degree of uncertainty. As a result, actual results in these areas may differ significantly from our estimates. For a discussion of our significant accounting policies and critical accounting estimates, see Item 7, "Management’s Discussion and Analysis of Financial Condition and Results of Operations — Significant Accounting Policies and Critical Accounting Estimates," and Note 2, "Summary of Significant Accounting Policies," to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019. There have been no significant changes in our significant accounting policies or critical accounting estimates during the first nine months of 2020, with the exception of credit losses. See Note 18, "Financial Instruments — Accounts Receivable," to the condensed consolidated financial statements included in this Report.
Recently Issued Accounting Pronouncements
For information on the impact of recently issued accounting pronouncements, see Note 19, "Accounting Pronouncements," to the condensed consolidated financial statements included in this Report.
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by us or on our behalf. The words "will," "may," "designed to," "outlook," "believes," "should," "anticipates," "plans," "expects," "intends," "estimates," "forecasts" and similar expressions identify certain of these forward-looking statements. We also may provide forward-looking statements in oral statements or other written materials released to the public. All such forward-looking statements contained or incorporated in this Report or in any other public statements which address operating performance, events or developments that we expect or anticipate may occur in the future, including, without limitation, statements related to business opportunities, awarded sales contracts, sales backlog and ongoing commercial arrangements, or statements expressing views about future operating results, are forward-looking statements. Actual results may differ materially from any or all forward-looking statements made by us. Important factors, risks and uncertainties that may cause actual results to differ materially from anticipated results include, but are not limited to:
- general economic conditions in the markets in which we operate, including changes in interest rates or currency exchange rates;
- the impact of the COVID-19 pandemic on our business and the global economy;
- changes in actual industry vehicle production levels from our current estimates;
- fluctuations in the production of vehicles or the loss of business with respect to, or the lack of commercial success of, a vehicle model for which we are a significant supplier;
- the outcome of customer negotiations and the impact of customer-imposed price reductions;
- the cost and availability of raw materials, energy, commodities and product components and our ability to mitigate such costs;
- disruptions in relationships with our suppliers;
- the financial condition of and adverse developments affecting our customers and suppliers;
- risks associated with conducting business in foreign countries;
- currency controls and the ability to economically hedge currencies;
- global sovereign fiscal matters and creditworthiness, including potential defaults and the related impacts on economic activity, including the possible effects on credit markets, currency values, monetary unions, international treaties and fiscal policies;
- competitive conditions impacting us and our key customers and suppliers;
- labor disputes involving us or our significant customers or suppliers or that otherwise affect us;
- the operational and financial success of our joint ventures;
- the impact and timing of program launch costs and our management of new program launches;
- limitations imposed by our existing indebtedness and our ability to access capital markets on commercially reasonable terms;
- changes affecting the availability of LIBOR;
- changes in discount rates and the actual return on pension assets;
- impairment charges initiated by adverse industry or market developments;
- our ability to execute our strategic objectives;
- disruptions to our information technology systems, or those of our customers or suppliers, including those related to cybersecurity;
- increases in our warranty, product liability or recall costs;
- the outcome of legal or regulatory proceedings to which we are or may become a party;
- the impact of pending legislation and regulations or changes in existing federal, state, local or foreign laws or regulations;
- the impact of regulations on our foreign operations;
- costs associated with compliance with environmental laws and regulations;
- developments or assertions by or against us relating to intellectual property rights;
- the impact of potential changes in tax and trade policies in the United States and related actions by countries in which we do business;
- the anticipated changes in economic and other relationships between the United Kingdom and the European Union; and
- other risks described in Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019, as supplemented and updated by Part II — Item 1A, "Risk Factors,” in this Report, and our other Securities and Exchange Commission ("SEC") filings.
The forward-looking statements in this Report are made as of the date hereof, and we do not assume any obligation to update, amend or clarify them to reflect events, new information or circumstances occurring after the date hereof.
Controls and procedures
As filed, 1,582 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) Disclosure Controls and Procedures
The Company has evaluated, under the supervision and with the participation of the Company’s management, including the Company’s President and Chief Executive Officer along with the Company’s Senior Vice President and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this Report. The Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Based on the evaluation described above, the Company’s President and Chief Executive Officer along with the Company’s Senior Vice President and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective to provide reasonable assurance that the desired control objectives were achieved as of the end of the period covered by this Report.
(b) Changes in Internal Control over Financial Reporting
There was no change in the Company’s internal control over financial reporting that occurred during the fiscal quarter ended October 3, 2020, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 6,252 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, except for the addition of the risk factor set forth below:
- Pandemics or disease outbreaks, such as COVID-19, have disrupted, and may continue to disrupt, our business, which could adversely affect our financial performance.
Pandemics or disease outbreaks, such as COVID-19, have disrupted, and may continue to disrupt, the global economy. The COVID-19 pandemic has led to a dramatic reduction in economic activity worldwide. International, federal, state and local public health and governmental authorities have taken extraordinary actions to contain and combat the outbreak and spread of COVID-19 throughout most regions of the world, including travel bans, quarantines, "stay-at-home" orders and similar mandates that have caused many individuals to substantially restrict their daily activities and many businesses to curtail or cease normal operations.
The automotive industry has been particularly negatively impacted by the evolving situation with a sudden and sharp decline in consumer demand and automotive manufacturers suspending or severely limiting automobile production globally. We have experienced, and may continue to experience, reductions in orders from our customers globally, which in turn has adversely affected, and may continue to affect, our financial performance. This reduction in orders may be further exacerbated by the global economic downturn resulting from the pandemic, which could decrease consumer demand for vehicles or result in the financial distress of one or more of our customers or suppliers. As described in more detail under "Our industry is cyclical and a decline in the production levels of our major customers, particularly with respect to models for which we are a significant supplier, or the financial distress of one or more of our major customers could adversely affect our financial performance" and "Adverse developments affecting or the financial distress of one or more of our suppliers could adversely affect our financial performance" in Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019, decreases in consumer demand for automotive vehicles, declines in the production levels of our major customers, financial distress of one or more of our major customers or suppliers or other adverse developments affecting one or more of our suppliers, could adversely affect our financial performance. In addition, if COVID-19 were to affect a significant amount of the workforce employed or operating at our facilities, we could experience delays or the inability to produce and deliver products to our customers on a timely basis.
Unprecedented industry disruptions related to the COVID-19 pandemic impacted operations in every region of the world. Our operations in China were impacted first, with most plants in the country closed for several weeks during the first quarter of 2020, resulting in significant decreases in vehicle production. Beginning in mid-March 2020, our operations in Europe, North America, South America and Asia (outside of China) were impacted, with virtually all of our plants closed at the end of the first quarter and closures continuing throughout April and, in most cases, a portion of May. As described in more detail under "Our substantial international operations make us vulnerable to risks associated with doing business in foreign countries" in Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019, our substantial international operations make us vulnerable to risks associated with doing business in foreign countries.
While all of our global manufacturing plants have resumed production, we may experience unexpected delays or obstacles, such as higher employee absenteeism, supply chain disruptions or government mandates, that may hamper our ability to fully resume operations. Further, we may not be able to operate at optimal levels of efficiency given new work rules and procedures that will need to be implemented to protect our employees. The suspension of production at our manufacturing facilities, or difficulties or inefficiencies in resuming production, would likely adversely impact our future results of operations, financial condition and liquidity, and that impact may be material.
As described in more detail under "Our existing indebtedness and the inability to access capital markets could restrict our business activities or our ability to execute our strategic objectives or adversely affect our financial performance" in Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019, the volatility created by COVID-19 could adversely affect our access to the debt and capital markets. In addition, our ability to continue implementing important strategic initiatives and capital expenditures may be reduced as we devote time and other resources to responding to the impacts of the COVID-19 pandemic.
COVID-19 continues to spread globally and the extent to which our financial performance will be adversely affected will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the pandemic, its severity, the effectiveness of actions to contain the virus or treat its impact and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts on our business and financial performance as a result of its global economic impact, including a recession that has occurred or may occur in the future, which will likely result in lower demand for new vehicles for a period of time, as new vehicle sales are typically correlated with positive consumer confidence and low unemployment.
The COVID-19 pandemic may also exacerbate other risks disclosed in Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019, including, but not limited to, our competitiveness, demand for our products and shifting consumer preferences.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-10-03. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-05 to 2020-10-03 | $4.90bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-01-01 to 2020-10-03 | $11.80bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-07-05 to 2020-10-03 | $4.46bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-01-01 to 2020-10-03 | $11.15bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2020-07-05 to 2020-10-03 | $147.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-01-01 to 2020-10-03 | $442.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-07-05 to 2020-10-03 | $278.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-01 to 2020-10-03 | $157.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-07-05 to 2020-10-03 | $26.5m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-01-01 to 2020-10-03 | $78.1m | us-gaap:InterestExpense |
| Income tax | 3 months2020-07-05 to 2020-10-03 | $44.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-10-03 | $30.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-05 to 2020-10-03 | $174.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-10-03 | −$43.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-07-05 to 2020-10-03 | $2.89 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-01-01 to 2020-10-03 | −$0.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-07-05 to 2020-10-03 | $2.90 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-01 to 2020-10-03 | −$0.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-07-05 to 2020-10-03 | 60,330,941 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-01 to 2020-10-03 | 60,260,886 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-01 to 2020-10-03 | $262.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2020-07-05 to 2020-10-03 | $90.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months2020-01-01 to 2020-10-03 | $285.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2020-01-01 to 2020-10-03 | $52.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2020-01-01 to 2020-10-03 | $70.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-10-03 | $1.25bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-10-03 | $6.60bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-10-03 | $12.89bn | us-gaap:Assets |
| Current liabilities | At period end2020-10-03 | $5.05bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2020-10-03 | $2.30bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-10-03 | $18.9m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2020-10-03 | $4.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2020-10-03 | $4.13bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-20-049114. Last ingested by Listed: Nov 10, 2026, 04:47 ET. Listed shows no prices and gives no investment advice.